Evaluation of preterm infants having bronchopulmonary dysplasia with echocardiography and serum biomarkers.

Ozge PamukcuN NarinS SunkakA Tuncay

Published in: Cardiology in the young (2023)

In the diagnosis and the follow-up of pulmonary hypertension in bronchopulmonary dysplasia patients, besides echocardiography kallistatin, gelsolin, NT-probrain natriuretic peptide, homocysteine, and cystatin-C levels can be used. Further studies were required with large sample sizes.

Keyphrases

pulmonary hypertension
preterm infants
end stage renal disease
left ventricular
computed tomography
newly diagnosed
ejection fraction
pulmonary artery
chronic kidney disease
prognostic factors
patient reported outcomes